Absorbable Tissue Spacer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Absorbable Tissue Spacer market is segmented by Product Type (Hydrogel Based Spacers, Biodegradable Balloon Spacers), Application (Radiotherapy, Infection Management), End-User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

Market Snapshot

ATS
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Absorbable Tissue Spacer market studied is anticipated to grow with a CAGR of nearly 4.9%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer and advantages associated with tissue spacer.

Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades.

Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.

Scope of the Report

As per the scope of the report, absorbable tissue spacers refers to bioabsorbable tissue spacers made of various materials such as nonwoven fabrics, polymers, hydrogels and a few injectable materials, which are used to provide adequate protection and also to produce a strong protective barrier during radiotherapy, thus showing a more concentrated effect on target tissues.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Hydrogel-based Spacers Hold Significant Share in the Global Absorbable Tissue Spacer Market

  • Hydrogel based tissue spacers have usage across many fields of cancer. Prostate-rectum hydrogel spacer application is a relatively safe technical procedure that is well tolerated and has a high technical success rate. Spacer application significantly reduces rectal radiation dose and results in long-term reductions in rectal toxicity, as well as improvements in bowel, urinary, and sexual quality of life.
  • Various recent clinical trial results have demonstrated that the prostate-rectum spacer application technique is safe and well tolerated, and that the space created significantly reduces rectal injury during radiation therapy, leading to long-term clinical benefits. A clinically significant reduction in radiation therapy complication rates leads to improved patient outcomes, reduced toxicity concerns, and hopefully overall cost reductions.
seg ats.PNG

North America Dominates the Global Absorbable Tissue Spacer Market

As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. In order to tackle such challenges, extensive research in the field of diagnostics has been undertaken.

The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, has provided the potential for researchers to invest more in developing absorbable tissue spacers. Hence, owing to the aforementioned factors, the entire region is expected to hold the major share in the global absorbable tissue spacer market.

geo ats.png

Competitive Landscape

The global Absorbable Tissue Spacer market is competitive and consists of a few major players. Companies like Biocomposites, Bioprotect Ltd., Boston Scientific, CR Bard, Palette Life Sciences., among others, hold a substantial market share in the market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cancer

      2. 4.2.2 Advantages associated with Tissue Spacer

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost and Lack of Skilled Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Hydrogel Based Spacers

      2. 5.1.2 Biodegradable Balloon Spacers

    2. 5.2 By Application

      1. 5.2.1 Radiotherapy

      2. 5.2.2 Infection Management

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Biocomposites

      2. 6.1.2 Bioprotect Ltd.

      3. 6.1.3 Boston Scientific

      4. 6.1.4 BD (CR Bard)

      5. 6.1.5 Palette Life Sciences

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Absorbable Tissue Spacer Market market is studied from 2018 - 2026.

The Absorbable Tissue Spacer Market is growing at a CAGR of 4.9% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bioprotect Ltd. , Biocomposites , Palette Life Sciences, Boston Scientific (Augmenix, Inc), BD (CR Bard) are the major companies operating in Absorbable Tissue Spacer Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!